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ABSTRACT 
 
Peganum harmala.  belongs to Asian Origin and grows in the Middle East and in part of South mainly 
in India and Pakistan, is a plant of the family Nitrariaceae. It is a perennial plant which can grow to about 0.8 m 
tall. The aim of this study is to overview its therapeutic effects than its nutritive and industrial effects. This review 
article was carried out by searching studies in PubMed, Medline, Web of Science, and Iran Medex databases up to 
2016.totally, of 85 found articles, 40 articles were included. The search terms were “Peganum harmala.”, 
“therapeutic”, “pharmacological”. Various studies have shown that Peganum harmala. possess Candidiasis 
,Biological ,Anti- cholinesterase, Anti- tumor angiogenesis, Antiparasitic effect, Anti-inflammatory effect, 
Cerebroprotective effect, Cytotoxicity effect, Antioxidant effect ,Hepatoma cancer effect, AhR ligands-mediated 
effects, Hepatoprotective prevention effect, Hypoglycemic effect, Pesticide effect, Antibacterial effect, Theileriosis 
effect, Antimicrobial effect, Analgesic effect, Histo-functional effects, Antinociceptive effects ,Antitumor effect, 
Haemosporidian infections in cattle effect, Haemosporidian infections effect, Abortificient potential effect. Peganum 
has different properties and combinations and numerous medicinal properties of its extract, essential oils, its stems 
and leaves require more research about the other beneficial and unknown properties of this plant. 
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INTRODUCTION 
 
It is proved that herbal medicine is effective in the treatment of many diseases [1-10]. 
Peganum harmala, belongs to Asian Origin and grows in the Middle East and in part of South Asia mainly 
in India and Pakistan, is a plant of the family Nitrariaceae. It is a perennial plant which can grow to about 0.8 m tall, 
the plant's seeds are especially noteworthy because they have seen continual use for thousands of years in the rites of 
many cultures. 
 
The roots of the plant can reach a depth of up to 6.1 m, if the soil where it is growing is very dry. It blossoms 
between June and August in the Northern Hemisphere. The flowers are white and are about 2.5–3.8 cm in 
diameter. The round seed capsules measure about 1–1.5 cm in diameter, have three chambers and carry more than 
50 seeds[4-8].  
 
Peganum harmala has been used to treat pain and to treat skin inflammations, including skin cancers[11, 12]. 
Peganum harmala has been used as an emmenagogue and abortifacient agent. The "root is applied to kill lice" and 
when burned, the seeds kill insects and inhibit the reproduction of the Tribolium castaneum beetle. It is also used as 
an anthelmintic [to expel parasitic worms]. Reportedly, the ancient Greeks used the powdered seeds to get rid 
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of tapeworms and to treat recurring fevers [possibly malaria]. A red dye, "Turkey red", from the seeds [but usually 
obtained from madder] is often used in western Asia to dye carpets. It is also used to dye wool. When the seeds are 
extracted with water, a yellow fluorescent dye is obtained. If they are extracted with alcohol, a red dye is 
obtained. The stems, roots and seeds can be used to make inks, stains and tattoos[5-8].  
 
In large quantities, it can reduce spermatogenesis and male fertility in rats. Harmine, a compound present in 
Peganum harmala, fluoresces under ultraviolet light . Peganum harmala has been shown to have antibacterial and 
anti-protozoal activity, including antibacterial activity against drug-resistant bacteria [7, 13]. One of the compounds 
found in P. harmala, vasicine [peganine], has been found to kill Leishmania donovani, a protozoan parasite that can 
cause potentially fatal visceral leishmaniasis.  
 
Another alkaloid, harmine, found in P. harmala, has appreciable efficacy in destroying intracellular parasites in the 
vesicular forms[2,3]. A small study in sheep infected with the protozoal Theileriahirci found Peganum 
harmala extract to be an effective treatment. Peganum harmala for sale at a market in Kazakhstan.Seed extracts also 
show effectiveness against various tumor cell lines, both in vitro and in vivo. "The beta-carboline alkaloids present 
in medicinal plants, such as Peganum harmala and Eurycoma long if olio, have recently drawn attention due to their 
antitumor activities. Further mechanistic studies indicate that beta-carboline derivatives 
inhibit DNA topoisomerases and interfere with DNA synthesis." Peganum harmala has antioxidant and 
antimutagenic properties. Both the plant and the extract harmine exhibit cytotoxicity with regards to HL60 and K562 
leukemiacelllines [7-9]. 
 
Candidiasis 
The inhibitory effect of phenolic compounds and alkaloids of Inonotus hispidus and Peganum harmala on Candida 
rugosa lipase and their antioxidant activities was investigated. The results have shown that the phenolic and the 
alkaloid extracts are good inhibitors of C. rugosa lipase. Thus, the inhibitor molecules (harmaline and hispidin) have 
been isolated from P. harmala and I. hispidus. These isolated molecules could be used in the treatment of 
candidiasis [14]. 
 
Anti-inflammatory  
Potential in vivo acute anti-inflammatory, analgesic activities, and in vitro antioxidative capacity of this plant was 
evaluated. Findings demonstrate that formulation cream of P. harmala seeds oil has an interesting anti-inflammatory 
activity with a slight peripheral analgesic effect due mainly to its richness on linoleic acid, γ-tocopherol, and 
polyphenols and to its important antioxidant capacity [15]. 
 
Anti- cholinesterase 
Its inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) was evaluated. Bioassay-
guided fractionation has led to the isolation of AChE and BChE inhibitors from the seeds of P. harmala. The results 
are in agreement with the traditional uses of the seeds of P. harmala [16]. 
 
Anti- tumor angiogenesis  
The anti-angiogenic effects of heat and low pH stable hydroalcoholic extract of P. harmala seeds on endothelial 
cells (ECs) proliferation was investigated .result indicated that hydroalcoholic extract of P. harmala seeds contains a 
potent anti-angiogenic component, which exerts its inhibitory effect mainly through down-regulation of essential 
mediators such as VEGF (17). 
 
Antiparasitic effect 
The antiparasitic effect of a methanolic extract of Peganum harmala was explored. the results revealed that weight 
gain, feed intake, and feed conversion ratio (FCR) were depressed significantly in Ph-0 group with significant 
mortality percentage. Weight gain, total body weight, and FCR increased linearly with increasing dose of P. 
harmala with the exception of feed intake. The growth and feed efficiency of Ph-0/NC was better in Ph-0/NC 
compared to that in Ph-0/C and comparable to that in P. harmala-treated birds. [18]. 
 
Peganum harmala total alkaloids extracts and pure β-carboline compounds as an anti-inflammatory treatment by the 
inhibition of an enzyme key of inflammatory, myeloperoxidase (MPO) and HPLC quantification of the alkaloids 
from the different parts of plant was evaluated. The inhibition of MPO by Peganum harmala β-carboline alkaloids, 
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herein reported for the first time, may explain the anti-inflammatory effect traditionally attributed to its herbal 
medicine[19]. 
 
Cerebroprotective effect 
The harmine alkaloids from the seeds of Peganum harmala (TAPH) and its cerebroprotective effect on cognitive 
deficit mice was isolated. The results showed that it reduces the metabolism of epinephrine, 5-HT and other 
monoamines and enhances the action of these neurotransmitters indirectly; this adrenergic system plays an important 
role in learning and memory. harmine alkaloids are potential enough to utilize in the management of 
Neurodegenerative disorders of the type Alzheimer's diseases[20]. 
 
Cytotoxicity 
Components in P. harmala seed-extract responsible for the cytotoxic effects was examined. The harmala alkaloids 
inhibited the growth of four tumor cell lines, and proliferation of Jurkat cells with varying potencies. Harmine was 
the most potent in inhibiting cell growth, and vasicinone was most active as anti-proliferating substance. The TAF 
had significant cytotoxic as well as antiproliferating activity (21). 
 
A novel triterpenoid and a phenolic glycoside were isolated and identified, as well as seven known compounds. OA 
showed the highest cytotoxicity against human lung cancer cells. OA had a potent anti-NSCLC cell activity by 
interfering with the epidermal growth factor receptor (EGFR) activation and its downstream signaling, and could 
exert an antiproliferative effect by inactivation of EGFR-driven antiapoptotic pathway followed by the release of 
mitochondrial cytochrome c, which might prove to be a promising leading compound for the development of an 
anti-lung cancer drug [22]. 
 
Antioxidant  
The curative effect of the 132 KD protein isolated from the seeds of Peganum harmala [P. harmala] L. against 
carbon tetrachloride induced oxidative stress in rats was evaluated. The isolated protein possessed strong antioxidant 
activity comparable to that of BSA [negative control] and vitamin C [positive control] [23]. 
 
The effects of ethanol extracts of P. harmala seeds on the olive fruit fly, Bactroceraoleae [Rossi] [Diptera: 
Tephritidae], i.e., adult repellency, reproductive activity, and larval growth, as well as parasitism levels by 
Psyttaliaconcolor [Szépligeti] was investigated. There was a slightly prolonged developmental time from egg to 
adult. Parasitism of larval B. oleae by P. concolor was not affected by infested fruit treatment with 2% P. harmala 
extract. P. harmala extracts as a potential control for insect pest species are discussed [24]. 
 
Hepatomacancer 
The effect of P. harmala extract on the expression of different cytochrome P450's [CYP] involved in drug 
metabolism was examined in human HepG2 cells. Results showed that P. harmala extract significantly increased the 
expression of CYP1A2, 2C19, and 3A4 whereas; CYP 2B6, 2D6 and 2E1 was significantly decreased. We 
concluded that care should be taken when P. harmala is co-administered with other drugs [25]. 
 
AhR ligands-mediated effects 
The ability of the methanolic extract of Peganum harmala L. [Zygophyllaceae] fruiting tops to affect TCDD-
activated AhR-mediated signal transduction in mouse hepatoma Hepa 1c1c7 cells was examined. Results showed 
that Peganum harmala extract significantly inhibited the TCDD-mediated induction of Cyp1a1 at mRNA, protein, 
and activity levels. Both of the active alkaloids showed an inhibitory effect on TCDD-induced Cyp1a1 activity level. 
We concluded that Peganum harmala L. can interfere with AhR ligands-mediated effects [26]. 
 
Hepatoprotective prevention 
The putative protective effects of ethanol and chloroform extracts of Peganum harmala on thiourea-induced 
diseases in adult male rat was characterized. Result show that ethanol and chloroform extracts of Peganum harmala 
protected the animal against the carcinogenic effects induced by thiourea since neuron-specific enolase [NSE] and 
thyroglobulin [TG] levels were back to the normal range [27]. 
 
Hypoglycemic effect 
The hypoglycemic activity of the ethanolic extract of this plant at two dose levels of 150 and 250mg/kg bw in 
sucrose challenged normal as well as in rats with streptozotocin induced diabetes was examined. The results show 
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that the ethanolic extract of P. harmala is as effective as metformin in reducing the blood glucose levels of 
normoglycemic and streptozotocin-induced diabetic rats [28]. 
 
Pesticide effect 
The leaf extract and its fractions of Peganum harmala L. have shown pronounced mortal effect, decreased percent 
pupation and adult emergence of the cotton leaf worm, Spodopteralittoralis Boisd. The medicinal plant P. harmala 
could be carefully applied in integrated pest management due to its strong effect on cotton leaf worm pest [29]. 
 
Antibacterial effect 
The antimicrobial potential of various extracts from 12 medicinal plants has been investigated in vitro on multiple 
antibiotic resistant pathogens and some selected protozoa isolated from poultry. It is concluded that Peganum 
harmala or its alkaloids could probably be used for the control of antibiotic resistant isolates of bacteria as well as 
protozoa[30]. 
 
Theileriosis 
In an animal study, lambs were treated for internal and external parasite before commencement of the experiment. 
The lambs were experimentally infected with T. hirci by placing ticks Hyalommaanatolicumanatolicum infected 
with T. hirci on them. After treatment, the clinical signs and parasites in the lymph node smears of the animals in 
Group A disappeared and they all animals recovered. These parameters in the animals of Group B progressed until 
their death. Pathological studies showed the characteristic lesions of theileriosis in lambs in Group B, but not in 
Group A. The results indicate a therapeutic effect of the alkaloids of P. harmala for treatment of ovine malignant 
theileriosis [31]. 
 
Antimicrobial 
Its efficacy on the course of colibacillosis and effects of long-term feeding on selected parameters of general health 
in chickens was investigated. It showed that the crude extract of Peganum harmala possesses limited antimicrobial 
activity against E. coli in vivo and long-term continuous feeding may induce undesired effects. Furthermore, the 
study underlines the value of in vivo experiments and the diverse picture that herbal products, in this case Peganum 
harmala, may deliver by testing them against specific pathogens [32]. 
 
Analgesic effect 
The antinociceptive action was assayed in several experimental models in mice: writhing, formalin, and hot plate 
tests. These result showed that the alkaloid extract of Pgh contains active analgesic principles acting both centrally 
and peripherally. Furthermore, this antinociceptive effect has been avoided by naloxone at a dose of 1mg/kg in the 
first phase of formalin and hot plate tests indicating that this extract act partly through an opioid-mediated 
mechanism. In conclusion, the alkaloid extract of Peganum harmala seems to have both central and peripheral 
antinociceptive activities which may be mediated by opioid receptors [33]. 
 
Histo-functional effects 
Effects of Peganum harmala on the reproductive system and fertility using adult male albino rats was examined. 
The aqueous extracts of Peganum harmala might have adverse effects on the processes of spermatogenesis due to 
direct or indirect effects on somniferous tubules and or the pituitary testicular axis[34]. 
 
Antinociceptive effects  
The protective effect of Peganum harmala-extract [P-extract] and the two major alkaloids [harmine and harmaline] 
from the seeds of P. harmala against CuSO4-induced LDL oxidation was investigated. Harmaline had a markedly 
higher antioxidant capacity than harmine in scavenging or preventive capacity against free radicals as well as 
inhibiting the aggregation of the LDL protein moiety [apolipoprotein B] induced by oxidation. The results suggested 
that P. harmala compounds could be a major source of compounds that inhibit LDL oxidative modification induced 
by copper [35]. 
 
the effect of Peganum harmala [Syrian rue] a wild-growing flowering plant belonging to the family Zygophylaceae 
and found abundantly in Iran on formalin-induced pain response in mice was evaluated. Harmaline, the last step of 
extraction is the main effective antinociceptive agent of the Peganum harmala alkaloid extract [36]. 
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Antitumor  
Some aspects of the antineoplastic properties of the plant Peganum was investigated. Results obtained indicate that 
alkaloids of Peganum have a high cell toxicity in vitro. The active principle at a dose of 50 mg/kg given orally to 
mice for 40 days was found to have significant antitumoural activity. Peganum harmala alkaloids thus possess 
significant antitumour potential, which could prove useful as a novel anticancer therapy [12]. 
 
Haemosporidian infections in cattle 
Cattle experimentally infected with Babesiabigemina or Theileriasergenti or mixed infestations of the two parasites 
were treated with Total Alkaloid of Peganum harmala L. The results showed that treatment was effective against B. 
bigemina infection, had a marked effect on the course of infection with T. sergenti and some effect on the course of 
the mixed infection [37]. 
 
Haemosporidia infections  
Eighty two cattle naturally infected with haemosporidians were treated with total alkaloid hydrochloride of 
Peganum harmale L. The results suggested that the curative effect of total alkaloid of P. harmale was better than 
that of diminazeneaceturate and produced minimal side effects. The alkaloid could also be administered to pregnant 
animals. It was concluded that the total alkaloid of P. harmale showed a marked effect as a treatment for 
haemosporidican infections in cattle [38]. 
 
Treatment with Peganum harmala extract remarkably increased the mitotic index in Allium cepa root tips with 
increasing treatment duration at all exposure times used and with almost all concentrations. The extract caused a 
relatively high increase in the mitotic index after a long period of treatment with some low concentrations [39]. 
 
Abortifacient potential  
The effect of methanol and acetone extracts of the epigeal parts of Peganum harmala, a common medicinal plant 
among Bedouins in Israel, was studied on several parameters of reproduction in female rats. The methanol extract at 
a dose of 2.5 g/kg/day, offered in food or in drinking suspension for 30 days, significantly prolonged diestrus by 1.0 
day. The methanol extracts at doses of 2.0, 2.5 and 3.5 g/kg/day appeared to produce a dose-dependent significant 
decrease in litter size. No change in the physical and nutritional status of the animals and no adverse toxicological 
effects were observed [40]. 
 
REFERENCES 
 
[1] Miraj S, Azizi N, Kiani S. Der Pharm Lett, 2016, 8 (6):229-237. 
[2] Miraj S   ,Kiani S. Der Pharm Lett, 2016, 8 (9):276-280. 
[3] Miraj S,  Kiani S. Der Pharm Lett, 2016, 8 (6):59-65. 
[4] Miraj S ,Kiani S. Der Pharm Lett. 2016;8 (6):59-65. 
[5] Miraj S ,Kiani S Der Pharm Lett. 2016;8 (9):137-140. 
[6] Miraj S  ,Kiani S. Der Pharm Lett, 2016, 8 (6):328-334. 
[7] Miraj S .Environ Monit Assess. 2016;188(6):320. 
[8] Sha’bani N, Miraj S, Adv Biomed Res. 2015;4. 
[9] Baghbahadorani FK, Miraj S. Electron Physician. 2016;8(5):2436. 
[10] Masoudi M, Miraj S, Rafieian-Kopaei M. J Clin Diagn Res.  2016;10(3):QC04. 
[11] Khlifi D, Sghaier RM, Amouri S, Laouini D, Hamdi M, Bouajila J. Food chem toxicol. 2013;55:202-8. 
[12] Lamchouri F, Settaf A, Cherrah Y, Zemzami M, Lyoussi B, Zaid A, et al. Therapie. 1998;54(6):753-8. 
[13] Al-Shamma A, Drake S, Flynn D, Mitscher L, Park Y, Rao G, et al.J nat prod. 1981;44(6):745-7. 
[14] Benarous K, Bombarda I, Iriepa I, Moraleda I, Gaetan H, Linani A, et al Bioorg Chem. 2015;62:1-7. 
[15] Khadhr M, Bousta D, Hanane E, El Mansouri L, Boukhira S, Lachkar M, et al. HPLC and GC-MS . Am J Ther. 
2016. 
[16] Yang Y, Cheng X, Liu W, Chou G, Wang Z, Wang C. J  ethnopharmacol. 2015;168:279-86. 
[17] Yavari N, Emamian F, Yarani R, Reza Mohammadi-Motlagh H, Mansouri K, Mostafaie A. Pharm Biol. 
2015;53(6):855-61. 
[18] Tanweer AJ, Saddique U, Bailey C, Khan R. Parasitol Res. 2014;113(8):2951-60. 
[19] Bensalem S, Soubhye J, Aldib I, Bournine L, Nguyen AT, Vanhaeverbeek M, et al. J ethnopharmacol. 
2014;154(2):361-9. 
[20] Biradar S, Joshi H, Tarak K. Pak J Biol Sci. 2013;16(23):1687. 
Sepideh Miraj Der Pharmacia Lettre, 2016, 8 (13):161-166 
______________________________________________________________________________ 
166 
Scholar Research Library 
[21] Lamchouri F, Zemzami M, Jossang A, Abdellatif A, Israili ZH, Lyoussi B.Pak J Pharm Sci. 2013;26(4):699-
706. 
[22] Wang C, Zhang Z, Wang Y, He X. Chem Biodivers. 2016. 
[23] Soliman AM, Abu-El-Zahab HS, Alswiai GA Asian Pac J Trop Med. 2013;6(4):285-95. 
[24] Rehman JU, Wang X-G, Johnson MW, Daane KM, Jilani G, Khan MA, et al. J Econ Entomol. 
2009;102(6):2233-40. 
[25] El Gendy MA, El-Kadi AO. Drug metab lett. 2009;3(4):212-6. 
[26] El Gendy MA, Somayaji V, El-Kadi AO. Planta med. 2010;76(07):671-7. 
[27] Hamden K, Masmoudi H, Ellouz F, ElFeki A, Carreau S. J Environ Biol.2007;29(1):73. 
[28] Singh AB, Chaturvedi J, Narender T, Srivastava AKIndian .J Clin Biochem. 2008;23(4):391-3. 
[29] Shonouda M, Osman S, Salama O, Ayoub A. Pak J Biol Sci. 2008;11(4):546-52. 
[30] Arshad N, Zitterl‐Eglseer K, Hasnain S, Hess M. Phytother  Res. 2008;22(11):1533-8. 
[31] Derakhshanfar A, Mirzaei M. Onderstepoort J Vet Res.. 2008;75(1):67-72. 
[32] Arshad N, Neubauer C, Hasnain S, Hess M. Poult Sci. 2008;87(2):240-9. 
[33] Farouk L, Laroubi A, Aboufatima R, Benharref A, Chait A. J Ethnopharmacol. 2008;115(3):449-54. 
[34] El-Dwairi QA, Banihani SM .Neuro Endocrinol Lett. 2007;28(3):305-10. 
[35] Berrougui H, Isabelle M, Cloutier M, Hmamouchi M, Khalil A. J Pharm Pharmacol. 2006;58(7):967-74. 
[36] Monsef HR, Ghobadi A, Iranshahi M, Abdollahi M.J Pharm Pharm Sci. 2004;7(1):65-9. 
[37] Fan B, Liang J, Men J, Gao F, Li G, Zhao S, et al. Trop Anim Health Prod. 1997;29(4):77S-83S. 
[38] Hu T, Fan B, Liang J, Zhao S, Dang P, Gao F, et al. Trop Anim Health Prod. 1997;29(4):72S-6S. 
[39] Abderrahman S. Cytobios. 1996;90(362-363):171-4. 
[40] Shapira Z, Terkel J, Egozi Y, Nyska A, Friedman J. J  ethnopharmacol. 1989;27(3):319-25. 
 
 
